Case Studies

USA, August 2005 -As Universities Get Billions in Grants, Some See Abuses

Visit Case Study

India, May 2012 – Probe finds collusion between India’s drug regulator, pharma firms

Visit Case Study

UK, January 2015 – The truth about cash referrals

Visit Case Study

Hong Kong, May 2016 – Gov’t dentist charged by corruption watchdog for falsifying records to claim free services for brother

Visit Case Study

Australia, April 2016 – Nurofen maker Reckitt Benckiser fined in Australia

Visit Case Study

UK, June 2016 – Compliance cover-up sees Astellas suspended from ABPI

Visit Case Study

UK, September 2016 – Freshers warned to be smart and avoid Modafinil

Visit Case Study

The Pharmaceuticals & Healthcare Programme is an international programme of Transparency International, based in the London office of Transparency International UK.

Contact Us